1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Bain Capital Specialty Finance amended its senior secured revolving credit agreement, extending both the revolver availability period and the scheduled maturity date and increasing the total facility amount. The filing says other terms of the credit agreement were materially unchanged, and the company's ability to borrow under the revolver is extended further into the future.
Total facility amount increased from $855 million to $905 million
Revolver availability period extended from May 19, 2028 to July 26, 2030
Scheduled maturity date extended from May 18, 2029 to July 28, 2031
XPEL, Inc. disclosed that director Mark Thornton resigned from its Board of Directors effective immediately on July 30, 2026. The company says the resignation was not due to any disagreement over its operations, policies, or practices, but because his employer adopted a policy barring him from serving on the Board.
Mark Thornton resigned as a board member effective immediately, notified July 30, 2026
Resignation was not related to any disagreement with the company on operations, policies, or practices
Reason given: a new policy adopted by Thornton's employer prohibits him from serving on the Board
The Board thanked Thornton for his service and contributions
Pinnacle Financial Partners amended a letter agreement with Robert A. McCabe, Jr., extending his service as Chief Banking Officer and Vice Chair of the Board from December 31, 2026 to December 31, 2027. The company also amended its bylaws to reflect the extended term, and McCabe will receive a $1,150,000 annual consulting fee for two years after his service ends.
Term as Chief Banking Officer and Vice Chair extended from December 31, 2026 to December 31, 2027
Amendment to the letter agreement signed July 29, 2026; bylaw amendment effective July 29, 2026
Post-service consulting fee of $1,150,000 per year over a two-year consulting period
Southern California Edison furnished a July 30, 2026 business update presentation, to be used in meetings with investors and analysts and posted on edisoninvestor.com. The deck restates a $38 billion to $41 billion electric infrastructure investment opportunity for 2026 through 2030, and reports wildfire mitigation progress and the state's SB 254 wildfire funding changes, including an estimated SCE share of $145 million per year starting in 2029.
Electric infrastructure investment opportunity of $38 billion to $41 billion from 2026 through 2030, with a ~7% 2025-2030 rate base CAGR.
As of June 30, 2026, 7,170+ miles of covered conductor installed and ~90% visual coverage of the High Fire Risk Area; up to ~970 miles of remaining planned hardening to be completed through 2028 under the approved GRC.
SB 254 (signed September 19, 2025): SCE share of the new Continuation Account is 47.85%, about $145 million per year starting in 2029; SCE's share of the $6 billion securitization is ~$2.9 billion.
The Eaton Fire slide states SCE is currently unable to estimate potential losses.
J.W. Mays, Inc. entered a transition agreement with CFO Ward Lyke, who will remain as Vice President, Chief Financial Officer, and Treasurer until September 25, 2026, then resign. The company said his departure is not related to any disagreement, and Controller Kevin Guptar will become Principal Financial Officer and Principal Accounting Officer upon Lyke's separation.
Ward Lyke's separation date is September 25, 2026; his base salary continues at $316,000 until then.
Lyke may receive six weeks of base salary as separation benefits, conditioned on signing a release.
Kevin Guptar, the current Controller, becomes Principal Financial Officer and Principal Accounting Officer effective immediately upon Lyke's separation.
Hanmi Financial Corporation sold $55.0 million of 6.50% fixed-to-floating subordinated notes due 2036 in a private placement on July 30, 2026. The company plans to use the proceeds, along with general corporate funds, to redeem its $110.0 million of 3.75% subordinated notes due 2031, and the notes are intended to count as holding company Tier 2 capital. For shareholders, the filing shows a financing that replaces higher-cost 2031 debt with a smaller issue, and it does not include new earnings or guidance.
$55.0 million of 6.50% subordinated notes due July 31, 2036 issued to qualified institutional buyers and institutional accredited investors
Notes fixed at 6.50% until July 31, 2031, then float at Three-Month Term SOFR plus 234 basis points
Company gave notice to redeem all $110.0 million of 3.75% notes due 2031 at par plus accrued interest, expected on or about September 1, 2026
Notes are intended to qualify as Tier 2 capital at the holding company level; cannot be redeemed before the fifth anniversary of issuance
Columbia Banking System, Inc. appointed Simone Lagomarsino to its Board of Directors on July 28, 2026, effective September 1, 2026. Her seat on the Columbia Bank board is subject to approval by the Oregon Department of Consumer and Financial Services. She will serve on the Audit and Enterprise Risk Management committees, and her director pay is set by the company's 2026 non-employee director program.
Appointment effective September 1, 2026; Columbia Bank board seat subject to Oregon regulator approval
Will serve on the Audit Committee and the Enterprise Risk Management Committee
Annual cash retainer of $95,000 and annual equity retainer of $115,000, prorated for the partial year
Restricted stock award from the equity retainer vests in full on May 14, 2027
The trust replaced its previous sub-adviser, Octagon Credit Investors, with King Street's Rockford Tower unit under an interim agreement effective July 30, 2026, while a shareholder vote on a permanent agreement was adjourned to August 6, 2026. The adviser, investment objective, and 1.70% advisory fee are unchanged, and the new sub-adviser's fee is 52% of that advisory fee.
Special Meeting to approve the New Sub-Advisory Agreement adjourned to August 6, 2026 to solicit more proxies
Interim Sub-Advisory Agreement with Rockford Tower Asset Management effective July 30, 2026, replacing Octagon Credit Investors
Sub-advisory fee set at 52% of the 1.70% annual advisory fee; reimbursable expenses capped at 0.07% per annum of average daily net assets
Mr. Young Choi became lead portfolio manager and Mr. Terry Ing became a portfolio manager
ImmunityBio announced on July 29, 2026 that the UAE's Emirates Drug Establishment granted marketing authorization for ANKTIVA in BCG-unresponsive non-muscle invasive bladder cancer and in metastatic non-small cell lung cancer after checkpoint inhibitor failure. The filing says this brings ANKTIVA's regulatory footprint to 34 countries, but it contains no revenue, sales, or financial results, so the direct financial effect on shareholders is not quantified.
UAE authorization granted with first registration in July 2026 and validity through July 2031.
Bladder cancer indication (with BCG) covers CIS with or without papillary tumors, described as the first worldwide to span the full spectrum of BCG-unresponsive disease.
Lung cancer indication (with checkpoint inhibitors) covers metastatic NSCLC after progression; median overall survival was 14.6 months in the 79-patient QUILT-3.055 study.
ImmunityBio's regional partner in the UAE is Modern Pharmaceutical Company.
Franklin Resources entered into a Second Amended and Restated Credit Agreement with Bank of America as administrative agent, replacing its existing $1.5 billion revolving credit agreement. The new five-year facility extends maturity to July 30, 2031, and allows an optional increase of up to $500 million; $700 million was outstanding at closing. The filing describes this as a refinancing and extension of existing borrowing capacity rather than a new source of cash beyond the amounts already drawn.
New five-year revolving credit facility with $1.5 billion of commitments, maturing July 30, 2031, with an option to increase by up to $500 million
$700 million outstanding under the facility as of July 30, 2026, rolled over from the terminated Original Credit Agreement, which was scheduled to mature April 30, 2030
Covenant requires a consolidated net leverage ratio of no greater than 3.25 to 1.00, tested quarterly
Soulpower Acquisition Corp. and SWB Holdings said the Virgin Islands Commercial Division court granted, on July 23, 2026, permission for the joint liquidators of Bank of Asia (BVI) Limited to sell certain assets to SWB LLC. The approval satisfies one of the conditions of the November 6, 2025 Asset Sale Agreement, but the filing says other conditions remain outstanding and SWB still needs a banking licence and deposit protection approval before it can engage in banking activities.
On July 23, 2026, the High Court granted the joint liquidators permission to sell certain Bank of Asia (BVI) Limited assets to SWB LLC or its affiliate, successor or designee.
Other Asset Sale Agreement conditions remain outstanding; SWB has submitted a banking licence application to the British Virgin Islands Financial Services Commission, which is under review.
The proposed business combination remains subject to closing conditions, including approval by Soulpower shareholders, and Pubco intends to file a Form S-4 registration statement.
Aldeyra Therapeutics executed a lease on July 28, 2026 for about 4,067 square feet of office space at 23 Bradford Street in Concord, Massachusetts, to serve as its corporate headquarters. The lease starts September 1, 2026 and runs through September 30, 2029, with monthly base rent of $12,201.00 plus operating expenses and taxes. This is a routine administrative agreement with limited direct financial effect on shareholders.
Lease covers about 4,067 square feet at 23 Bradford Street, Concord, Massachusetts, with Bradford Street, L.L.C.
Term begins September 1, 2026 and ends September 30, 2029; base rent is $12,201.00 per month and increases annually.
Company will post an initial security deposit of $50,000.00 and pay additional operating expenses, taxes and fees.
Allegiant Travel disclosed three financing arrangements tied to its aircraft fleet. A $231.0 million PDP facility from Runway Seven Lender LLC, guaranteed by the company, is undrawn and matures March 31, 2028, and a separate $177.5 million Airbus-secured credit facility is also undrawn. In July 2026 the company drew $132.0 million on a $176.0 million Boeing 737 MAX facility, which is now fully drawn, so its debt obligations are rising as aircraft are delivered.
July 27, 2026: amendment to PDP facility with Runway Seven Lender LLC, $231.0 million commitment for Boeing pre-delivery payments, maturing March 31, 2028, undrawn
July 24, 2026: credit facility of up to $177.5 million secured by certain Airbus aircraft, undrawn, with quarterly amortizing payments beginning July 2027 over five to six years
July 2026: borrowed $132.0 million under a previously reported $176.0 million facility secured by Boeing 737-MAX aircraft, now fully drawn, with 10-year terms
ORIC Pharmaceuticals' board approved an amended and restated 2022 Inducement Equity Incentive Plan effective July 28, 2026, adding 1,100,000 shares for a total of 3,350,000 shares reserved for equity awards. The plan was adopted without stockholder approval under Nasdaq rules and is limited to inducement grants to new hires or acquisition-related awards, so it adds to potential future share issuance.
Board approved an additional 1,100,000 shares, bringing the total reserved under the Inducement Plan to 3,350,000 shares of common stock.
Approved effective July 28, 2026, and adopted without stockholder approval under Nasdaq Listing Rules.
Awards may be granted only to individuals not previously employees or non-employee directors, as an inducement to employment or, where permitted, in connection with a merger or acquisition.
The full plan is filed as Exhibit 10.1 to the 8-K.
Atlantic Union Bankshares completed an underwritten public offering of $250 million in 6.25% fixed-to-floating rate subordinated notes due August 1, 2036, on July 30, 2026. The notes are unsecured subordinated debt that pays 6.25% fixed until August 1, 2031, then a floating rate tied to SOFR plus 213 basis points.
Offering size: $250 million aggregate principal amount of 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036
Fixed 6.25% coupon, paid semi-annually, from July 30, 2026 to August 1, 2031; floating rate of Three-Month Term SOFR plus 213 basis points thereafter, paid quarterly
Company may redeem at par plus accrued interest on or after August 1, 2031, or earlier under specified tax, regulatory capital or investment company events
DXC Technology said Chris Drumgoole will resign as President, Global Infrastructure Services, effective July 30, 2026, and appointed Paul J. Taylor as President, DXC, effective August 10, 2026. Taylor will lead the company's global operating business, which the press release describes as an approximately $13 billion business, and Dan Gray will become President of Global Infrastructure Services. The filing reports no financial results and no separation arrangements for Drumgoole.
Chris Drumgoole resigns as President, Global Infrastructure Services, effective July 30, 2026, with no disagreement cited and no separation arrangements
Paul J. Taylor appointed President, DXC effective August 10, 2026, with a $1,000,000 U.S. dollar base salary and a one-time inducement equity award with a grant-date value of $3.75 million
Dan Gray named President of Global Infrastructure Services; Drumgoole joins a newly formed CEO Advisory Council
Clear Secure's board appointed Rob O'Hare, currently chief financial officer of Affirm Holdings, as a director effective July 30, 2026, and increased the board to ten directors. He joins the Audit Committee, and Tomago Collins rotates off that committee at the same time.
Appointed director and Audit Committee member effective July 30, 2026; term runs to the 2027 annual meeting
Initial RSU grant valued at $480,000, vesting in three equal annual installments
Vail Resorts appointed William Hornbuckle, CEO and President of MGM Resorts International, as a director on July 29, 2026, effective August 3, 2026. The Board expanded from nine to ten members to make room for him. As a non-employee director, he will receive the company's standard director compensation, and the filing reports no related party transactions.
Board appointment made July 29, 2026, effective August 3, 2026; Board size increased from nine to ten members
Hornbuckle, age 68, has been CEO, President and a director of MGM Resorts International since July 2020
No arrangements or understandings tied to his appointment, and no related party transactions requiring disclosure
Company press release dated July 30, 2026 is filed as Exhibit 99.1
Lumentum Holdings said Executive Vice President of Global Reliability & Quality Vincent Retort informed the company on July 27, 2026 that he plans to retire effective in October 2026. He has agreed to provide consulting services for a two-year term after retirement, and his outstanding equity awards will keep vesting during that term if he remains a service provider.
Vincent Retort, Executive Vice President, Global Reliability & Quality, plans to retire effective October 2026.
Notice given to the company on July 27, 2026; the 8-K was filed July 30, 2026.
Retort will provide consulting services to Lumentum for a two-year term after retirement.
His outstanding equity awards continue to vest during the consulting term on existing schedules, provided he remains a service provider.
On July 22, 2026, B&R Technology Merger Corp. completed its initial public offering of 32,500,000 units at $10.00 per unit, generating $325 million in gross proceeds. The full $325 million was placed in a U.S.-based trust account held by Continental Stock Transfer & Trust Company, and the company has 24 months from the IPO closing (or 27 months if it signs a definitive agreement in that period) to complete an initial business combination, or it must redeem the public shares.
32,500,000 units sold at $10.00 each; each unit includes one Class A ordinary share and one-third of one redeemable warrant exercisable at $11.50 per share
Sponsor bought 687,500 private placement units at $10.00 each, for gross proceeds of $6,875,000
$325,000,000 placed in the trust account with Continental Stock Transfer & Trust Company as trustee
Underwriter holds a 45-day option to buy up to 4,875,000 additional units; it did not exercise the option at closing
Dorian LPG's Board approved an amended and restated Executive Severance and Change in Control Severance Plan on July 24, 2026, revising the definition of "Change in Control" to remove certain carve-outs. The company says the change aligns the plan with its 2014 Equity Incentive Plan and reflects its current shareholder base.
Board approved the amended Severance Plan on July 24, 2026, on the compensation committee's recommendation.
The change removes certain carve-outs from the "Change in Control" definition.
The revised definition is intended to match the definition in the Second Amended and Restated 2014 Equity Incentive Plan.
Full plan filed as Exhibit 10.1; the filing gives no financial figures for the change.
Netflix disclosed that director Anne Sweeney resigned from its Board of Directors effective July 26, 2026. The company said her resignation was not due to any disagreement with Netflix, which suggests a routine board change rather than a dispute. The filing does not name a replacement or give a reason beyond the absence of disagreement.
Anne Sweeney notified Netflix of her board resignation on July 26, 2026, effective that date
Netflix states the resignation is not due to any disagreement with the company
The filing does not name a successor or a reason for the departure
AnaptysBio disclosed that the Court granted a joint stipulation setting the post-trial briefing schedule in its consolidated litigation with Tesaro and GlaxoSmithKline, following a trial held July 14-17, 2026. The filing contains no ruling on the merits, so the outcome of the dispute remains unresolved for shareholders.
Trial of the consolidated Tesaro litigation was held July 14-17, 2026.
The Court granted the parties' Joint Stipulation on July 28, 2026.
AnaptysBio's opening post-trial brief is due August 21, 2026, and post-trial argument is set for October 20, 2026.
On July 29, 2026, Yarrow Bioscience closed an exchange in which an existing stockholder swapped 133,290 shares of common stock for pre-funded warrants to buy the same number of shares at $0.0001 per share. After the exchange, the company has 2,669,788 common shares and pre-funded warrants for 25,914,530 shares outstanding, so the potential future share count is far larger than the common shares currently outstanding. Shareholders may care because those warrants could add to the number of shares outstanding if exercised.
Exchange closed July 29, 2026: 133,290 common shares exchanged for pre-funded warrants at a $0.0001 exercise price
Pre-funded warrants are immediately exercisable and can be exercised in full, subject to a 9.99% beneficial ownership limit
Limit may be raised or lowered up to 19.99% on 61 days' notice to the company
After the exchange: 2,669,788 common shares and pre-funded warrants for 25,914,530 shares outstanding
Fortune Brands Innovations said its Executive Vice President, Chief Legal Officer and Corporate Secretary, Hiranda S. Donoghue, will leave the company effective July 31, 2026, after a qualifying termination without cause. Jack N. Melamed, the company's Vice President, Deputy General Counsel and Assistant Secretary, will serve as interim Chief Legal Officer and Corporate Secretary until a permanent successor is identified. The filing says her departure is not due to any disagreement over the company's operations, policies or practices.
Hiranda S. Donoghue departs effective July 31, 2026; the decision was made July 24, 2026
Jack N. Melamed to serve as interim Chief Legal Officer and Corporate Secretary; no permanent successor named
Donoghue is eligible for benefits under her existing termination agreement, as described in the March 30, 2026 proxy statement
Filing states the departure is not the result of any disagreement with the company
Astec Industries expanded its board from nine to ten members and appointed William E. Waltz as an independent director, effective October 29, 2026. Waltz will also join the Compensation Committee and currently serves as President and CEO of Atkore, Inc.
Board increased from nine to ten members; Waltz appointed effective October 29, 2026
Waltz, age 62, is President and CEO and a director of Atkore, Inc. (NYSE: ATKR), positions held since 2018
Waltz will serve an initial term expiring at the 2027 annual meeting and joins the Compensation Committee
Board determined Waltz is independent; he will receive the standard non-employee director compensation
AiRWA Inc. completed its acquisition of Hong Kong Best Life Trade Co., Limited on July 30, 2026, paying the seller $30 million in USDT for 100% of the shares of Best Life's holding company, which gives AiRWA a 97% equity interest. The remaining $20 million of the base purchase price is due within 90 days of closing, and the consideration includes contingent earn-out payments tied to previously disclosed revenue milestones. The filing does not disclose Best Life's financial results, so shareholders cannot yet judge the deal's effect on earnings.
Closed July 30, 2026, after being announced July 27, 2026
$30 million paid in USDT; remaining $20 million payable within 90 days of closing
AiRWA holds a 97% equity interest in Best Life; earn-outs depend on revenue milestones
Pro forma and acquired-business financial statements to be filed by amendment within 71 calendar days
On July 28, 2026, AAON's board increased from nine to eleven members and appointed Robert L. Buttermore III and Patrick J. Jermain as independent Class III directors, effective immediately. The board also amended the bylaws to raise the maximum board size from nine to eleven. The filing discloses no financial results or changes to the company's operations.
Board size increased from nine to eleven on July 28, 2026, under a First Amendment to the Amended and Restated Bylaws.
Robert L. Buttermore III is Senior Vice President and Chief Supply Chain Officer at Rockwell Automation and joins the Compensation Committee.
Patrick J. Jermain recently retired as Executive Vice President and Chief Financial Officer of Plexus Corporation after twelve years as CFO and joins the Audit Committee.
Both new directors' terms expire at the annual meeting of stockholders in May 2027.
Tennant Company said Chief Financial Officer Fay West has given notice she will retire after a successor is hired and a transition period occurs, with retirement expected in the second quarter of 2027 and no earlier than April 2, 2027. The company has started searching for a successor and aims to name one by the first quarter of 2027, so shareholders get a long runway for the handover.
Fay West gave notice on July 27, 2026, of her intention to retire as SVP and Chief Financial Officer
Retirement expected in the second quarter of 2027, no earlier than April 2, 2027
Company aims to name a successor by the first quarter of 2027
CEO Dave Huml thanked West for her role in financial discipline and the company's growth strategy
Ambow Education Holding Ltd. announced general availability of the HybriU AI Adaptive Course Generation Platform, a new product within its HybriU AI-powered platform, on July 30, 2026. The filing describes the product as a way to turn any topic or body of institutional knowledge into a personalized learning application, and it is the third HybriU product launch of 2026. The filing contains no financial results, pricing or revenue figures, so the launch's effect on shareholders cannot be measured from this document.
Product made generally available globally on July 30, 2026 through desktop and mobile web
Filing cites Grand View Research projection that the global corporate training market will reach $458 billion in 2026
Third HybriU product launch of 2026, following HybriU Collaboration Board and HybriU ProjectHub
No revenue, pricing or financial figures disclosed; enterprise pricing inquiries directed to ir@ambow.com
Central Plains Bancshares, Inc. said its Board approved on July 28, 2026 a submission to regulators for a new stock repurchase program covering up to 417,481 shares, about 10.0% of current outstanding shares. The program would replace the company's current repurchase program once adopted, and it cannot proceed without regulatory non-objection.
Board approved regulatory submission of new repurchase program on July 28, 2026
Program covers up to 417,481 shares, approximately 10.0% of current outstanding shares
Upon adoption, the new program would replace the current repurchase program
Details were disclosed in a press release dated July 29, 2026 (Exhibit 99.1)
Green Brick Partners said its President and Chief Operating Officer, Jed Dolson, will be promoted to Co-Chief Executive Officer on October 15, 2026, as part of the board's long-term succession planning. The filing reports no related party transactions and no other arrangements tied to the promotion, and it does not include financial results.
Jed Dolson, President and COO, will become Co-Chief Executive Officer effective October 15, 2026
Dolson joined the company in 2013 and served as President of Trophy Signature Homes from 2022 to 2024
CEO Jim Brickman said the promotion reflects more than a decade of leadership at the company
The announcement was made in a July 30, 2026 press release furnished as Exhibit 99.1
Cabot Corporation said its President and CEO, Sean Keohane, will retire and leave the board effective September 30, 2026. Erica McLaughlin, the company's current CFO, will become President and CEO and join the board effective October 1, 2026, and the company has started a search for a new CFO.
Keohane remains a non-executive employee through December 31, 2026 under a transition agreement.
McLaughlin's base salary rises to $910,000 per year effective October 1, 2026.
Target short-term incentive for McLaughlin rises to 120% of base salary for performance periods beginning in fiscal 2027.
The filing does not report a financial result for the period; the change is a leadership succession.
Lite Strategy said it bought back about 4.9 million shares, or 13% of shares outstanding when the program began, from December 2025 through July 17, 2026, at an average price of $1.11 for about $5.4 million. The company said the buybacks were funded from Litecoin sales and covered call premiums, and that its NAV discount narrowed from the low 40% range to below 25%, which raises Litecoin held per remaining share. The company also reported preliminary, unaudited fiscal year-end cash of $5.7 million and total liabilities of $1.1 million.
About 4.9 million shares repurchased through July 17, 2026, at an average price of $1.11, for about $5.4 million.
Company held 819,070 LTC against 31,882,648 shares outstanding as of July 17, 2026.
NAV discount narrowed to below 25% from the low 40% range during the repurchase period.
Preliminary, unaudited cash of $5.7 million and total liabilities of $1.1 million as of June 30, 2026; final results may differ materially.
Ambiq Micro's CEO published a letter on July 30, 2026, marking one year since the company began trading on the NYSE under AMBQ. The letter reports approximately $372 million in gross proceeds from an IPO and two follow-on offerings and describes product, software and customer progress, but the filing contains no earnings, guidance or financial results.
Company began trading on the NYSE under AMBQ on July 30, 2025.
Approximately $372 million raised in gross proceeds from one IPO and two follow-on public offerings during the first year.
Letter says about 80% of customers are integrating AI into product designs and introduces the Atomiq family with an integrated NPU.
Filed as Exhibit 99.1 under Item 7.01 and furnished, not filed, under the Exchange Act.
Tvardi Therapeutics said it selected ulcerative colitis (UC) as the initial disease indication for its oral STAT3 inhibitor TTI-109, following a completed Phase 1 healthy volunteer study. The company plans a UC clinical trial in 2027, subject to IND clearance and additional funding, and will host a key opinion leader webinar on August 19, 2026.
Phase 1 healthy volunteer study showed placebo-adjusted reductions in immune cell subsets, including up to 76% reduction in Th17-associated populations.
Company cites an addressable market of approximately $3 billion in the U.S. and $9 billion globally for UC.
Planned UC trial start in 2027 is subject to IND clearance and additional funding, and the company has not stated amounts of additional funding needed.
KOL webinar with Dr. Randy Longman is scheduled for Wednesday, August 19, 2026 at 11:00 AM ET.
Extreme Networks signed a new $500 million, five-year revolving credit agreement with JPMorgan Chase Bank as administrative agent, and used a borrowing under it to repay its existing Bank of Montreal credit agreement. As of the closing date, $200 million was drawn and $300 million remained available. The filing describes a routine refinancing that adds debt and covenant obligations, with no early termination penalties reported.
New $500 million revolving facility matures July 29, 2031, with $200 million outstanding at closing and $300 million available.
Existing credit agreement with Bank of Montreal, dated June 22, 2023, was terminated and fully repaid, with liens released.
Facility is secured by substantially all assets and requires a consolidated total net leverage ratio of no more than 3.75 to 1.00 and interest charge coverage of at least 3.00 to 1.00, starting with the quarter ending September 30, 2026.
Sirius XM said Executive Vice President and Chief Operating Officer Wayne D. Thorsen will cease serving as an employee effective July 31, 2026, and the company does not intend to appoint a successor COO at this time. Under a separation agreement, Thorsen will receive a $1,050,000 lump sum prorated bonus payment and his unvested equity awards will be forfeited.
Departure effective July 31, 2026; company does not plan to name a successor COO at this time
Separation agreement dated July 29, 2026 provides a $1,050,000 lump sum payment, prorated for 2026 annual bonus
Payment due within 60 days of separation date, subject to a general release of claims
All unvested equity awards outstanding as of July 31, 2026 will be forfeited without consideration
Henry Schein said it is creating the Henry Schein Leadership Team to replace its Executive Management Committee and is integrating its global supply chain organization with its global distribution group. COO Michael S. Ettinger, Chief Strategy Officer Mark E. Mlotek, and SVP Global Supply Chain James Mullins will transition out of their roles and into senior advisory roles, and the 8-K says the transitions are effective October 30, 2026.
Michael S. Ettinger (EVP and COO) and Mark E. Mlotek (EVP and Chief Strategy Officer) transition to senior advisory roles effective October 30, 2026
James Mullins, SVP Global Supply Chain, also transitions out of his role
Henry Schein Leadership Team (HSLT) replaces the Executive Management Committee
Ettinger and Mlotek are entitled to payments and benefits under the Executive Severance Plan
Southern Cross Acquisition I Corp., a blank check company, said holders of 11,500,000 units may separately trade the ordinary shares, warrants and rights included in the units starting July 31, 2026. The shares, warrants and rights will trade on Nasdaq under the symbols NCO, NCOOW and NCOOR, while unseparated units continue under NCOOU. The move is administrative and does not change the company's business or target search.
Separate trading of ordinary shares, warrants and rights begins on or about July 31, 2026.
Ordinary shares, warrants and rights trade as NCO, NCOOW and NCOOR; units remain NCOOU.
Holders must have brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
Futurewave Acquisition Corporation, a blank check company, said holders of its units may separately trade the ordinary shares, rights and warrants included in the units starting on or about July 31, 2026. Units not separated will keep trading under FWACU, and the separated securities are expected to trade under FWAC, FWACR and FWACW. The change is administrative and does not alter the securities' terms or the company's business.
Separate trading of ordinary shares, rights and warrants expected to begin on or about July 31, 2026
Separated securities expected to trade as FWAC (shares), FWACR (rights) and FWACW (warrants) on Nasdaq Capital Market
Each whole warrant entitles the holder to buy one ordinary share at $11.50; holders must work through their brokers with Continental Stock Transfer & Trust Company to separate units
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.